Cargando…

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome

BACKGROUND: Irritable bowel syndrome (IBS) is a pathologic condition characterized by changes in gut microbiome composition, low-grade inflammation, and disruption of intestinal wall permeability. The interaction between the gut microbiome and the disease manifestation remains unclear. The changing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivashkin, V., Poluektov, Y., Kogan, E., Shifrin, O., Sheptulin, A., Kovaleva, A., Kurbatova, A., Krasnov, G., Poluektova, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195381/ https://www.ncbi.nlm.nih.gov/pubmed/34115808 http://dx.doi.org/10.1371/journal.pone.0252930

Ejemplares similares

Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
por: Kovaleva, Aleksandra, et al.
Publicado: (2023)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial
por: Ivashkin, Vladimir T., et al.
Publicado: (2022)

Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022)

Molecular and cellular mechanisms of tight junction dysfunction in the irritable bowel syndrome
por: CHENG, PENG, et al.
Publicado: (2015)

Editorial: Role of matrix metalloproteinases and other inflammatory mediators in the disruption of the intestinal tight junction barrier
por: Al-Sadi, Rana, et al.
Publicado: (2023)

Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
por: Lee, Sung Hee
Publicado: (2015)

Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
por: Ivashkin, Vladimir, et al.
Publicado: (2023)

Exposure to Zinc Oxide Nanoparticles Disrupts Endothelial Tight and Adherens Junctions and Induces Pulmonary Inflammatory Cell Infiltration
por: Chen, Chen-Mei, et al.
Publicado: (2020)

Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex
por: Lee, Ju Yup, et al.
Publicado: (2020)

Adherence to the pro-inflammatory diet in relation to prevalence of irritable bowel syndrome
por: Salari-Moghaddam, Asma, et al.
Publicado: (2019)

Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin
por: Shinoda, Takehiro, et al.
Publicado: (2016)

Claudin Loss-of-Function Disrupts Tight Junctions and Impairs Amelogenesis
por: Bardet, Claire, et al.
Publicado: (2017)

Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M)
por: Awad, Karem, et al.
Publicado: (2023)

Tight junction disruption by cadmium in an in vitro human airway tissue model
por: Cao, Xuefei, et al.
Publicado: (2015)

NMR-Guided Repositioning of Non-Steroidal Anti-Inflammatory Drugs into Tight Junction Modulators
por: Tenno, Takeshi, et al.
Publicado: (2021)

Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines
por: Kumar, Sunil, et al.
Publicado: (2021)

Pro-inflammatory cytokines decrease the expression of tight junction proteins in Caco-2 intestinal epithelial cells through a process that is dependent on peroxynitrite formation and PARP activation
por: Sappington, PL, et al.
Publicado: (2002)

Natural Products: A Dependable Source of Therapeutic Alternatives for Inflammatory Bowel Disease through Regulation of Tight Junctions
por: Peng, Jing, et al.
Publicado: (2023)

COVID-19 disrupts the blood–testis barrier through the induction of inflammatory cytokines and disruption of junctional proteins
por: Peirouvi, Tahmineh, et al.
Publicado: (2021)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Tight Junctions in Cell Proliferation
por: Díaz-Coránguez, Mónica, et al.
Publicado: (2019)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Influence of endurance exercise training on antioxidant enzymes, tight junction proteins, and inflammatory markers in the rat ileum
por: Holland, A. Maleah, et al.
Publicado: (2015)

Oncogenic Raf-1 Disrupts Epithelial Tight Junctions via Downregulation of Occludin
por: Li, Danxi, et al.
Publicado: (2000)

Olaquindox disrupts tight junction integrity and cytoskeleton architecture in mouse Sertoli cells
por: Wu, Di, et al.
Publicado: (2017)

ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics
por: Ma, Yanlei, et al.
Publicado: (2017)

Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease
por: Norén, Elisabeth, et al.
Publicado: (2017)

Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens
por: Awad, Wageha A., et al.
Publicado: (2017)

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
por: Mitselou, Antigony, et al.
Publicado: (2020)

Airway tight junctions as targets of viral infections: Tight Junctions and Viral Infections
por: Linfield, Debra T., et al.
Publicado: (2021)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
por: Major, Giles, et al.
Publicado: (2014)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

Effect of pH and lipopolysaccharide on tight junction regulators and inflammatory markers in intestinal cells as an experimental model of weaning transition in dairy calves
por: Agustinho, B.C., et al.
Publicado: (2023)

EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals
por: Xia, Xue, et al.
Publicado: (2019)

Lipopolysaccharide Disrupts the Milk-Blood Barrier by Modulating Claudins in Mammary Alveolar Tight Junctions
por: Kobayashi, Ken, et al.
Publicado: (2013)

Kiwifruit protease Act d 1 compromises the intestinal barrier by disrupting tight junctions
por: Grozdanovic, Milica, et al.
Publicado: (2014)

Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2016)

Early Porcine Sapovirus Infection Disrupts Tight Junctions and Uses Occludin as a Coreceptor
por: Alfajaro, Mia Madel, et al.
Publicado: (2019)

Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review
por: Robles-Osorio, Ma Ludivina, et al.
Publicado: (2023)

Erratum: ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics
por: Ma, Yanlei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p4hujpcu0p5ngn9bfjh0c17fpv